Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan‐stimulated respiratory burst by ‘type IV’‐selective PDE inhibitors
Open Access
- 1 June 1991
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 103 (2) , 1339-1346
- https://doi.org/10.1111/j.1476-5381.1991.tb09790.x
Abstract
The cyclic nucleotide phosphodiesterase (PDE) of guinea‐pig eosinophils was partially characterized and the effects of selective inhibitors of PDE isoenzymes upon opsonized zymosan (OZ)‐stimulated respiratory burst were studied. PDE activity in eosinophil lysates appeared to be membrane‐associated, displayed substrate specificity for adenosine 3′: 5′ cyclic monophosphate (cyclic AMP) versus guanosine 3′: 5′ cyclic monophosphate (cyclic GMP) and was insensitive to cyclic GMP or Ca2+ and calmodulin. The non‐selective PDE inhibitor, 3‐isobutyl‐1‐methylxanthine caused a concentration‐dependent inhibition of both OZ‐stimulated hydrogen peroxide (H2O2) generation and cyclic AMP hydrolysis. The type IV‐selective PDE inhibitors, rolipram and denbufylline, also inhibited H2O2 generation and cyclic AMP hydrolysis in a concentration‐dependent manner whilst SK&F 94120 and Org 9935 (type III‐selective) and zaprinast (type Ia or V‐selective) were ineffective. Dibutyryl cyclic AMP, a cell‐permeable, non‐hydrolysable analogue of cyclic AMP, caused a concentration‐dependent inhibition of H2O2 generation stimulated by OZ. Dibutyryl cyclic GMP was ineffective. It is concluded that eosinophil respiratory burst activity induced by OZ can be regulated by intracellular cyclic AMP and that the levels of cyclic AMP are controlled exclusively by a rolipram‐ and denbufylline‐sensitive PDE isoenzyme that resembles a type IV species.Keywords
This publication has 43 references indexed in Scilit:
- Selectivity of action can be achieved with compounds acting at second messenger targetsTrends in Pharmacological Sciences, 1990
- Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitorsTrends in Pharmacological Sciences, 1990
- Interactions of formylmethionyl‐leucyl‐phenylalanine, adenosine, and phosphodiesterase inhibitors in human monocytes Effects on superoxide release, inositol phosphates and cAMPFEBS Letters, 1989
- Pharmacological studies with SK&F 94120, a novel positive inotropic agent with vasodilator activityJournal of Pharmacy and Pharmacology, 1986
- Characterization of cyclic-nucleotide phosphodiesterase activities in resting and N-formylmethionylleucylphenylalanine-stimulated human neutrophilsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1986
- Isoproterenol inhibition of isolated human neutrophil functionJournal of Allergy and Clinical Immunology, 1984
- INHIBITION OF HUMAN PULMONARY PHOSPHODIESTERASE ACTIVITY BY THERAPEUTIC LEVELS OF THEOPHYLLINEClinical and Experimental Pharmacology and Physiology, 1978
- H2O2 release from human granulocytes during phagocytosis. I. Documentation, quantitation, and some regulating factors.Journal of Clinical Investigation, 1975
- On the Evaluation of the Constants
V
m
and
K
M
in Enzyme ReactionsScience, 1952